4//SEC Filing
Bagai Shaun 4
Accession 0001641172-25-017832
CIK 0001574094other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:45 PM ET
Size
6.3 KB
Accession
0001641172-25-017832
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Bagai Shaun
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2025-07-01+102,498→ 102,498 totalExercise: $1.27→ Common Stock (102,498 underlying)
Footnotes (2)
- [F1]Represents an award of 21,072 incentive stock options and 81,426 non-qualified options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025.
- [F2]The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0001862613
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:45 PM ET
- Size
- 6.3 KB